Cargando…

Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc therapy

PURPOSE: To explore clinical and dosimetric predictors of acute hematologic toxicity (HT) in cervical cancer patients treated with concurrent chemotherapy and volumetric-modulated arc therapy (VMAT). METHODS AND MATERIALS: We retrospectively reviewed the clinical data of 184 cervical cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Xiaoyong, Ding, Zhen, Zeng, Qi, Feng, Lingling, Qiu, Chunyan, Chen, Dongjie, Lu, Jiawei, Li, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898435/ https://www.ncbi.nlm.nih.gov/pubmed/35248087 http://dx.doi.org/10.1186/s13014-022-02018-1

Ejemplares similares

Dosimetric Effect of Jaw Tracking in Volumetric-Modulated Arc Therapy
por: Thongsawad, Sangutid, et al.
Publicado: (2018)

Dosimetric and delivery characterizations of full-arc and half-arc volumetric-modulated arc therapy for maxillary cancer
por: Miura, Hideharu, et al.
Publicado: (2012)

Dosimetric advantage of volumetric modulated arc therapy in the treatment of intraocular cancer
por: Deng, Zhenxiang, et al.
Publicado: (2017)

Dosimetric comparison of tomotherapy and volumetric‐modulated arc therapy for children with neuroblastoma
por: Liu, Xia, et al.
Publicado: (2020)

Dosimetric impact of volumetric modulated arc therapy for nasopharyngeal cancer treatment
por: Franzese, Ciro, et al.
Publicado: (2021)

Dosimetric comparison of intensity modulated and volumetric arc radiation therapy for gastric cancer
por: LI, ZHIPING, et al.
Publicado: (2014)

CBCT-based volumetric and dosimetric variation evaluation of volumetric modulated arc radiotherapy in the treatment of nasopharyngeal cancer patients
por: Jin, Xiance, et al.
Publicado: (2013)

Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection
por: Romano, Alessandra, et al.
Publicado: (2022)

Dosimetric Comparisons of Volumetric Modulated Arc Therapy and Tomotherapy for Early T-Stage Nasopharyngeal Carcinoma
por: Li, Shan, et al.
Publicado: (2018)

Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus
por: Xu, Cai, et al.
Publicado: (2017)

Prognostic Significance of Absolute Lymphocyte Count/Absolute Monocyte Count Ratio at Diagnosis in Patients with Multiple Myeloma
por: Shin, Su-Jin, et al.
Publicado: (2013)

Hybrid volumetric-modulated arc therapy for postoperative breast cancer including regional lymph nodes: the advantage of dosimetric data and safety of toxicities
por: Doi, Yoshiko, et al.
Publicado: (2020)

A comprehensive dosimetric evaluation of using RapidArc volumetric‐modulated arc therapy for the treatment of early‐stage nasopharyngeal carcinoma
por: Kan, Monica W.K., et al.
Publicado: (2012)

A dosimetric evaluation of flattening filter-free volumetric modulated arc therapy in nasopharyngeal carcinoma
por: Fu, Guishan, et al.
Publicado: (2014)

Dosimetric analysis of isocentrically shielded volumetric modulated arc therapy for locally recurrent nasopharyngeal cancer
por: Lu, Jia-Yang, et al.
Publicado: (2016)

Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience
por: Springer, Andreas, et al.
Publicado: (2016)

Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2015)

Dosimetric comparison of TomoDirect, helical tomotherapy, and volumetric modulated arc therapy for postmastectomy treatment
por: Nobnop, Wannapha, et al.
Publicado: (2020)

Dosimetric sensitivity of leaf width on volumetric modulated arc therapy plan quality: an objective approach
por: Murtaza, Ghulam, et al.
Publicado: (2022)

Dosimetric impact of rotational setup errors in volumetric modulated arc therapy for postoperative cervical cancer
por: Tsujii, Katsutomo, et al.
Publicado: (2021)

The dosimetric underpinning of bladder filling criteria for prostate image-guided volumetric modulated arc therapy
por: Kong, Vickie, et al.
Publicado: (2023)

PB2279: REDUCED ABSOLUTE COUNT OF MONOCYTES IN PATIENTS CARRYING HEMATOLOGICAL NEOPLASMS AND SARS-COV2 BREAKTHROUGH INFECTION
por: Romano, A., et al.
Publicado: (2022)

Dosimetric differences among volumetric modulated arc radiotherapy (RapidArc) plans based on different target volumes in radiotherapy of hepatocellular carcinoma
por: Gong, GuanZhong, et al.
Publicado: (2013)

Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife(®) System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity(®): Outcomes, Toxicities and Dosimetric Evaluation
por: Di Franco, Rossella, et al.
Publicado: (2022)

Dosimetric Validation of Volumetric Modulated Arc Therapy with Three 6MV Beam-Matched Linear Accelerators
por: Ashokkumar, Sangaiah, et al.
Publicado: (2017)

Dosimetric effects of sectional adjustments of collimator angles on volumetric modulated arc therapy for irregularly-shaped targets
por: Ahn, Beom Seok, et al.
Publicado: (2017)

Dosimetric effect of body contour changes for prostate and head and neck volumetric modulated arc therapy plans
por: Sun, Lingyue, et al.
Publicado: (2019)

Reduction of systematic dosimetric uncertainties in volumetric modulated arc therapy triggered by patient-specific quality assurance
por: Mans, Anton, et al.
Publicado: (2022)

Dosimetric Comparision of Coplanar versus Noncoplanar Volumetric Modulated Arc Therapy for Treatment of Bilateral Breast Cancers
por: Bharati, Avinav, et al.
Publicado: (2023)

Low Multiplication Value of Absolute Monocyte Count and Absolute Lymphocyte Count at Diagnosis May Predict Poor Prognosis in Neuroblastoma
por: Tamura, Akihiro, et al.
Publicado: (2020)

SmartArc-based volumetric modulated arc therapy for endometrial cancer: a dosimetric comparison with helical tomotherapy and intensity-modulated radiation therapy
por: Yang, Ruijie, et al.
Publicado: (2013)

The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy
por: Cheng, Yuan-Kai, et al.
Publicado: (2022)

Volumetric modulated arc radiotherapy sparing the thyroid gland for early-stage glottic cancer: A dosimetrical analysis
por: KIM, EUN SEOK, et al.
Publicado: (2014)

Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment
por: Khalifa, Jonathan, et al.
Publicado: (2014)

Dosimetric benefits of intensity‐modulated radiotherapy and volumetric‐modulated arc therapy in the treatment of postoperative cervical cancer patients
por: Deng, Xia, et al.
Publicado: (2016)

Variations in dosimetric distribution and plan complexity with collimator angles in hypofractionated volumetric arc radiotherapy for treating prostate cancer
por: Li, Ming‐Hsien, et al.
Publicado: (2018)

Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy
por: Hirashima, Hideaki, et al.
Publicado: (2018)

Dosimetric Effect of Rotational Setup Errors in Single-Isocenter Volumetric-Modulated Arc Therapy of Multiple Brain Metastases
por: Selvan, Kasirajan Tamil, et al.
Publicado: (2019)

Dosimetric comparison of coplanar and non-coplanar volumetric-modulated arc therapy in head and neck cancer treated with radiotherapy
por: Gayen, Sanjib, et al.
Publicado: (2020)

Three-dimensional dose reconstruction-based pretreatment dosimetric verification in volumetric modulated arc therapy for prostate cancer
por: Jeong, Yuri, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4js5mcbla9l0eoi65f0f6b81km